BioSpace News Archive

BioMidwest

CinCor Pharma Raises $143 Million in Series B Financing

CinCor Pharma, Inc. (“CinCor”) today announced the completion of a $143 million Series B financing.

October 12, 2021
·
4 min read
Biotech Bay

BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies

BioCardia®, Inc. announced the issuance of U.S. Patent No: 11,141,568 for “Multi Directional Steerable Catheter” that further protects the Helix™ Biotherapeutic Delivery System and enhances its biotherapeutic delivery capabilities.

October 12, 2021
·
4 min read
Business

Certara Appoints Patrick F. Smith to President of Integrated Drug Development

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Patrick F. Smith, Pharm.D. as president of Integrated Drug Development (IDD), reporting to CEO William F. Feehery.

October 12, 2021
·
2 min read
Antioxidants to prevent Alzheimer’s disease

Research conducted by the PhD student Mohamed Raâfet Ben Khedher and the postdoctoral researcher Mohamed Haddad of the Institut national de la recherche scientifique has shown that an oxidation-antioxidant imbalance in the blood is an early indicator of Alzheimer’s disease, rather than a consequence.

October 12, 2021
·
3 min read
Drug Development

Astellas and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® (enfortumab vedotin-ejfv) with Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer

Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen Inc. (Nasdaq:SGEN) today announced that patient enrollment was completed in Cohort K of the phase 1b/2 EV-103 clinical trial (also known as KEYNOTE-869).

October 12, 2021
·
16 min read
Business

Shoreline Biosciences Appoints Scott Forrest, Ph.D., As Chief Business Officer

Shoreline Biosciences, Inc. today announced the appointment of Scott Forrest , Ph.D., as Chief Business Officer.

October 12, 2021
·
3 min read
Business

Heska Third Quarter 2021 Financial Results and Earnings Call Scheduled for November 4, 2021

Heska Corporation, a leading provider of advanced veterinary diagnostic and specialty products, will report its third quarter 2021 financial performance in a press release before the market opens on Thursday, November 4, 2021.

October 12, 2021
·
1 min read
Drug Development

SOFIE Submits Investigational New Drug Application to US FDA for Pancreatic Cancer Imaging

SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, achieves a major milestone with the filing of an IND application to the FDA for a radiopharmaceutical targeting Fibroblast Activation Protein Inhibitor (FAPI).

October 12, 2021
·
3 min read
BioMidwest

Lilly Confirms Date and Conference Call for Third-Quarter 2021 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2021 financial results on Tuesday, October 26, 2021 .

October 12, 2021
·
1 min read
Rakovina Therapeutics Presents at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

Rakovina Therapeutics Inc. today announced a summary of the Company’s presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, which was held virtually on October 7-10, 2021.

October 12, 2021
·
5 min read